MLH1 and Lynch syndrome: Moreover, due to the different mechanisms leading to microsatellite instability, MSI endometrial cancers are divided into sporadic MLH1 hypermethylation and Lynch-syndrome-associated EC, and these two groups respond differently to immunotherapy.